Related by context. All words. (Click for frequent words.) 65 Pertuzumab 65 Medidata Designer 63 Cardiotoxicity 63 HyACT 62 Electronic Brachytherapy 62 SIR Spheres 62 Neoadjuvant 61 bevacizumab Avastin 61 Phase Forward InForm 61 Dabigatran 61 RE LY 61 MammoSite RTS 60 PRECISE 60 ASTEROID 60 Taxotere ® 60 multicentre randomized 60 Viatronix V3D Colon 60 Procoralan 60 EchoCRT 60 Protelos 60 BioZ ICG 60 cediranib 60 HuMax EGFr 60 BRIM2 60 ivabradine 59 CLARITY TIMI 59 PREDICTIVE 59 relapsing multiple sclerosis 59 CT Colonography 59 prospective multicenter 59 balloon brachytherapy 59 ALTTO 59 Quinamed 59 Gefitinib 59 antiangiogenic therapy 59 Candesartan 59 Pemetrexed 59 rEEG 59 Erlotinib 59 clevidipine 59 Prospective Randomized 59 Cetuximab 59 Xanafide 59 PSMA ADC 59 HORIZONS AMI 58 Dasatinib 58 radiotherapy SBRT 58 multicenter randomized clinical 58 Bevacizumab 58 intraoperative radiotherapy 58 carotid artery stenting CAS 58 QTinno 58 COR Analyzer 58 VerifyNow 58 Endoscopic Ablation System 58 YONDELIS 58 Temsirolimus 58 DATATRAK eClinical ™ 58 Randomized Evaluation 58 oral Xeloda 58 Inovelon 58 SYNTAX 58 cinacalcet 58 tipranavir 58 sorafenib Nexavar 58 gefitinib Iressa 58 Gemzar ® 58 trastuzumab Herceptin 58 Vasogen Celacade 58 RE LY ® 58 ToGA 58 CIMZIA ™ 58 YONDELIS R 58 ixabepilone 58 Corus CAD 58 Locked Nucleic Acid LNA 58 trabectedin 58 CHARISMA trial 58 NeuroStar TMS Therapy 58 Onconase 57 KRAS mutation 57 neratinib 57 IORT 57 LentiVector 57 PREVENT IV 57 PROLARIS 57 RE LY trial 57 Zarnestra 57 Teysuno 57 Afatinib 57 exemestane Aromasin 57 CDISC ODM 57 CaPSURE 57 Roche Xeloda 57 REMINYL ® 57 xCELLigence System 57 Orazol 57 Virtual Histology 57 Val HeFT 57 immatics 57 Patient Outcomes 57 pertuzumab 57 oral diclofenac 57 metastatic neuroendocrine tumors 57 anti angiogenic therapy 57 Gemcitabine 57 Randomized Study 57 Telmisartan 57 Sipuleucel T 57 Moxifloxacin 57 Pfizer Sutent 57 Vascular Stent 57 Tocilizumab 57 Lenalidomide 57 Tesetaxel 57 ONTARGET 57 OncoVEX GM CSF 57 Xinlay 57 teriflunomide 57 Ivabradine 57 Glufosfamide 57 Varian linear accelerators 57 Tarvacin 57 Ophena 57 multicenter clinical 57 Pazopanib 57 Hexvix 57 strontium ranelate 57 ZACTIMA 57 imatinib mesylate Gleevec 57 NSABP B 57 canakinumab 57 sipuleucel T 57 prasugrel Effient 57 Aflibercept 57 Prostate Cancer Prevention 57 surrogate endpoint 57 ibandronate 57 CINQUIL 57 multicenter prospective 57 standard chemotherapy regimen 56 CardioFit 56 CALGB 56 Dalbavancin 56 invasive candidiasis 56 sunitinib malate 56 atrasentan 56 Trandolapril 56 MAGE A3 ASCI 56 Telemonitoring 56 Velcade bortezomib 56 antithrombotics 56 neoadjuvant 56 MRgFUS 56 IRESSA 56 SPIRIT IV 56 HORIZONS AMI trial 56 Nesiritide 56 EndoTAG TM -1 56 Kepivance 56 BCIRG 56 Zometa zoledronic acid 56 DEFLUX 56 nilotinib Tasigna 56 TEMODAL 56 DOXIL 56 chemotherapeutic regimen 56 Algo Suite 56 EOquin TM 56 neoadjuvant therapy 56 Sidec 56 Dataflow Manager 56 Tumor Response 56 relapsed MM 56 oral ridaforolimus 56 mycophenolate mofetil 56 superDimension 56 INTRABEAM 56 neoadjuvant treatment 56 GEMS TM 56 AIM HIGH 56 FASLODEX 56 STRIDE PD 56 ENDEAVOR IV 56 ClearPath HDR 56 Xelox 56 Tryton Side Branch 56 Vandetanib 56 sorafenib tablets 56 Renal Cell Carcinoma RCC 56 CIMZIA TM certolizumab pegol 56 ACOMPLIA R 56 Delcath Phase III 56 PROSTVAC TM 56 ACCORD Lipid 56 macrolide antibiotics 56 Abiraterone 56 Ovarian Cancer Screening 56 BrachySil TM 56 Mepact 56 Eluting Coronary Stent System 56 SUTENT ® 56 TASQ 56 Coronary Revascularization 56 Vidaza azacitidine 56 stereotactic body 56 registrational Phase 56 olaparib 56 Phase III VISTA 56 bortezomib Velcade 56 riociguat 56 multicenter randomized controlled 56 phase IIa clinical 56 randomized Phase IIb 56 recurrent GBM 56 Surgical resection 56 Etanercept 56 BRAF inhibitor 56 pan HDAC inhibitor 56 decitabine 56 Randomized controlled 56 Diabetic Neuropathy 56 Deforolimus 56 Randomized Phase III 56 DuraHeart 56 infliximab Remicade 56 Genasense ® 56 Group RTOG 56 FDG PET CT 56 Elitek 55 Amrubicin 55 IRX 2 55 Ozurdex 55 tesmilifene 55 Bexion 55 assessing T DM1 55 PLAC test 55 randomized discontinuation 55 Allovectin 7 ® 55 MammaPrint 55 ASPIRE HIGHER 55 NICE SUGAR 55 Adjuvant Breast Cancer 55 PRoFESS 55 Azedra 55 Immunotherapeutic 55 PRIALT 55 QTRAP 55 ELOXATIN 55 LUMINATE 55 vidofludimus 55 Capsule Endoscopy 55 Carfilzomib 55 proteasome inhibitor 55 ARB telmisartan 55 oral anticoagulation 55 Pirfenidone 55 phase IIb clinical 55 CAMO Software 55 TheraSphere 55 Epirubicin 55 RESOLUTE clinical 55 radionuclide therapy 55 hyperthermia therapy 55 Kahalalide F 55 Xeloda capecitabine 55 MADIT II 55 Oncotype DX Recurrence Score 55 Angiox R 55 tocilizumab 55 ACCOMPLISH 55 Scancell 55 Combination therapy 55 gemcitabine carboplatin 55 Permacol 55 dutasteride 55 abatacept Orencia 55 Infliximab 55 galiximab 55 RECIST Response Evaluation Criteria 55 DCVax 55 trials RCTs 55 QOPI 55 KRN# 55 Chronic Heart Failure 55 CHARM Added 55 BERKELEY CA UroToday.com 55 CHAMPION PCI 55 BARI 2D 55 lumiliximab 55 BENICAR HCT 55 eprotirome 55 Sorafenib 55 Sanvar 55 HIFU therapy 55 Solid Tumors 55 anti arrhythmic 55 biochemical profiling 55 radiofrequency ablation RFA 55 rFVIIa 55 AVOREN 55 Doxil ® 55 therapeutic regimens 55 phase IIIb 55 OPAXIO 55 Referenced EEG 55 Traficet EN 55 CYPHER SELECT TM 55 Esmya 55 ENESTnd 55 Adjuvant 55 NO# [002] 55 BENICAR 55 VitroGro 55 RhuDex 55 Medtronic CoreValve 55 Spine Patient Outcomes 55 Proxinium TM 55 Multicenter Automatic Defibrillator Implantation 55 regorafenib 55 goBalto 55 vitro ADME 55 DDW ® 55 prospective multicentre 55 CALGB # [001] 55 Advanced Renal Cell 55 Stenting Trial CREST 54 GW# [003] 54 Prostate AdenoCarcinoma Treatment 54 EXPAREL ™ 54 chemoembolization 54 Diabetic Foot Ulcer 54 CYPHER Stent 54 KRAS variant 54 RhuDex ® 54 Ambrisentan 54 Thorough QT 54 aldosterone antagonists 54 Noxafil 54 Talabostat 54 Fondaparinux 54 NSABP 54 multicenter Phase II 54 FibroScan ® 54 Blinatumomab 54 Phase #b/#a clinical 54 Phase IIIb study 54 trastuzumab DM1 54 prospective randomized controlled 54 IOERT 54 malignant pleural mesothelioma 54 Cardiac Resynchronization Therapy 54 XP #L 54 PD2i ® 54 SYNTAX trial 54 MoxDuo IR 54 Carotid Revascularization Endarterectomy vs. 54 doxorubicin docetaxel 54 Modulo Risk Manager 54 XGEVA 54 Hsp# Inhibitor 54 Phase IIIb clinical 54 Microdosing 54 glycemic variability 54 colon capsule endoscopy 54 ROCKET AF 54 nomograms 54 Hepatocellular Carcinoma HCC 54 ImmuKnow assay 54 Nexavar sorafenib 54 multimodality imaging 54 CupPrint 54 Nexrutine 54 antitumor effect 54 Intervention Effectiveness 54 REALITY Trial 54 National Emphysema Treatment 54 carotid stents 54 NeuroFlo 54 Certican 54 randomized controlled clinical trials 54 TYKERB 54 Removab 54 ActivityBase 54 Photocure 54 Invasive Breast Cancer 54 transcranial Doppler ultrasound 54 Tesmilifene 54 Response Evaluation Criteria 54 pharmacokinetic PK study 54 endoscopic ultrasound 54 VAPRISOL 54 ALVESCO R 54 CoFactor 54 neoadjuvant chemotherapy 54 Optical Coherence Tomography 54 Endo PAT 54 DAVANAT 54 trastuzumab DM1 T DM1 54 DATATRAK eClinical TM 54 Rasilez Tekturna 54 bronchial thermoplasty 54 EURIDIS 54 Adaptive Radiation Therapy 54 placebo controlled clinical 54 Femara letrozole 54 ASCO GI 54 PROactive study 54 VA# [002] 54 oral laquinimod 54 MoxDuo TM IR 54 ISEL 54 ACRIN 54 pemetrexed Alimta 54 Left Ventricular Dysfunction 54 Lung Cancer Screening 54 Oral Insulin 54 Percutaneous Coronary Intervention 54 Breast Density 54 Sentinel Lymph Node Biopsy 54 oral FTY# 54 chemoradiotherapy 54 protein biochip 54 TRIAS 54 ExTRACT TIMI 54 Angiographic 54 temsirolimus 54 viral kinetics 54 Veracity ™ 54 PFO migraine 54 Echocardiographic 54 Bayer HealthCare Onyx Pharmaceuticals 54 cilostazol 54 Fingolimod 54 Coronary Artery Bypass Graft 54 NCCN Drugs 54 multicenter randomized placebo controlled 54 HCV SPRINT 54 rt PA 54 everolimus eluting stents 54 Abatacept 54 Combination REOLYSIN R 54 Outpatient Setting 54 Betaferon R 54 PediGuard 54 BSGI MBI 54 pegylated interferon alfa 2b 54 MirixaPro 54 CARE HF 54 Aplidin 54 Secondary efficacy endpoints 54 predictive biomarkers 54 PD2i 54 Natalizumab 54 Overactive Bladder 54 Labguard ™ 54 Anticancer Drugs 54 therapy IMRT 54 Lipsovir ® 54 HE4 test 54 RezularTM 54 cobiprostone 54 Bionate ® PCU 54 Axxom 54 ketoprofen patch 54 agClinical NW 54 prospective nonrandomized 54 #F FDG PET 54 randomized Phase III 54 Fully Covered Stent 54 mprodigy 54 Paromomycin 54 XELOX 54 BeneFIX 54 Calci CLEAR 53 antihormonal 53 refractory metastatic 53 ICON7 53 ePRO solutions 53 aflibercept 53 preoperative chemotherapy 53 Randomised 53 adult chronic ITP 53 Tanespimycin 53 TMC# C# 53 atherothrombotic disease 53 dabigatran etexilate 53 RamSoft 53 NCCN guidelines 53 Phase III AFFIRM 53 renal tumors 53 carboplatin paclitaxel 53 Radiation Therapy Oncology 53 blinded randomized controlled 53 Arimidex anastrozole 53 Adalimumab 53 AZILECT ® 53 Eli Lilly Alimta 53 ELACYT 53 KINAXO 53 Syllego system 53 Yondelis ® 53 methodologically rigorous 53 double blinded randomized 53 Carotid 53 CCX# 53 biliary tract cancer 53 Exforge HCT 53 ALOXI 53 Pharmaceutical Profiles 53 Omnitarg 53 Interferon alfa 53 florbetaben 53 SYNTAX Score 53 CRLX# 53 TroVax ® 53 Phase Ib II 53 Betaferon ® 53 PhotoCure 53 Votrient 53 Capsule endoscopy 53 cetuximab Erbitux 53 CURRENT OASIS 7 53 ChiSys 53 Taxotere docetaxel 53 Avastin bevacizumab 53 mesalazine 53 nonmetastatic 53 SCCHN 53 ACUITY trial 53 Digital Mammographic Imaging 53 Severe Asthma 53 MGd 53 Akaza 53 terlipressin 53 CIPN 53 multicenter trials 53 unfractionated heparin UFH 53 Phase 1a clinical 53 Lp PLA 2 53 QTc prolongation 53 TAXUS ATLAS 53 Patient Registry 53 ACAM FLU 53 Emselex 53 pancreatic neuroendocrine tumors 53 KRAS status 53 Tracleer R 53 Allovectin 7 53 subanalysis 53 TORISEL 53 BenzaClin R 53 FFR measurement 53 Fragment Library 53 Boceprevir 53 depsipeptide 53 EndoPAT 53 InForm ITM 53 Marinomed 53 paclitaxel eluting stents 53 FDG-PET/CT 53 clinico pathological 53 Clinical Antipsychotic Trials 53 NCCN Compendium 53 clinically validated 53 Valdoxan 53 STELARA ™ 53 Pycnogenol ® 53 NCCTG N# 53 Alpharadin 53 anastrozole 53 Glycominds 53 Upfront CFD 53 EGIR 53 PLCO 53 RF ablation 53 Zysolin TM 53 reboxetine 53 thoracoscopic lobectomy 53 transrectal ultrasound guided 53 antithrombotic therapy 53 Randomized Phase 53 evaluating tivozanib 53 Ixempra 53 Darunavir 53 pharmacogenetic testing 53 Prostate Px + 53 tipranavir ritonavir 53 randomized blinded 53 EUS FNA 53 Perforomist ™ Inhalation Solution 53 EBUS FNA 53 ganetespib 53 BOLDER 53 NKI AVL 53 ATACAND 53 blinded randomized 53 OPTIMIZE 53 AccuBoost 53 EmbraceAC 53 trastuzumab Herceptin ® 53 Accuray CyberKnife 53 Eplerenone 53 Cellvizio 53 TRO# 53 Atacand ® 53 GeneSightRx 53 rosuvastatin Crestor 53 Referenced EEG ® 53 Ketotransdel TM 53 Metastatic Melanoma 53 Angiolix 53 Kibow 53 MEK inhibitors 53 SCD HeFT 53 Archexin 53 metastatic colorectal 53 Sporanox 53 SPIRIT FIRST 53 Medifacts 53 Interferon beta 53 randomized controlled trials RCTs 53 ABCSG 53 Rezular 53 Dose Escalation 53 deforolimus 53 Intervention Trial GAIT 53 SciVal Funding 53 MTWA testing 53 FDG PET imaging 53 Sym# 53 Bevacizumab Avastin 53 SIR Spheres microspheres 53 Pharm Olam 53 REOLYSIN ® 53 CAPHOSOL 53 AIR2 Trial 53 Everolimus 53 Ischemia 53 LUX Lung 53 GliaSite 53 TrialWorks 53 SWOG 53 ALLHAT 53 SUCCEED trial 53 Phase IIB 53 beta carotene supplementation 53 Diabetes Risk Score 53 Hemopurifier ® 53 DAPT Study 53 ThermoDox R 53 Biojector ® 53 antiplatelet therapies 53 endothelin antagonist 53 Qutenza TM 53 Clinicaltrials.gov 53 postoperative chemotherapy 53 AtherOx 53 Novartis Zometa 53 stereotactic radiotherapy 53 Randomized Phase II 53 GI motility disorders 53 adjuvant chemotherapy 53 SciVal 52 pharmacokinetic pharmacodynamic 52 VFEND 52 dose escalation clinical 52 Photodynamic Therapy 52 recurrent glioma 52 Desvenlafaxine 52 transient elastography 52 vinca alkaloid 52 ENDEAVOR III 52 MADIT CRT 52 EVEREST II 52 Erbitux cetuximab 52 Lapatinib 52 solid organ transplantation 52 iPrEx study 52 ofatumumab HuMax CD# 52 Endovascular System 52 Hycamtin 52 genomic profiling 52 LEXIVA r 52 HERmark 52 Benign Prostatic Hyperplasia 52 Retacrit 52 amifostine 52 TomTec 52 Sanvar R 52 Screening Trial DMIST 52 Genzyme Myozyme 52 Anticoagulation 52 investigational immunotherapy 52 ProSavin 52 alfuzosin 52 ActiPix 52 Aggressive Reduction 52 SORT OUT III 52 pregabalin Lyrica 52 HIPEC 52 AngioJet System 52 Aromasin exemestane 52 entinostat 52 Advexin 52 ProLindac 52 Delcath System 52 IVMD 52 Cloretazine ® 52 VisuMax 52 LEVAQUIN 52 Provantis 52 farletuzumab 52 Automated Breast Ultrasound 52 Bortezomib 52 ABSORB trial 52 treating uterine fibroids 52 sentinel lymph node biopsy 52 Enzastaurin 52 Innate Immune 52 ELCAP 52 Biphasic 52 DASISION 52 pretreatment serum 52 Xyrem ® 52 Dialysis Outcomes 52 Reveal XT 52 ADMIRE HF 52 MADIT 52 uterine fibroid embolization 52 pivotal bioequivalence 52 TrialMaster TM 52 forodesine 52 Glaxo Tykerb 52 Panzem 52 noninfectious uveitis 52 BEXXAR therapeutic regimen 52 Fabry Disease 52 elacytarabine 52 FOLFIRINOX 52 MIST Therapy 52 VESTASYNC 52 randomized controlled Phase 52 medavis 52 PharmaVigilant 52 non squamous NSCLC 52 Urodynamics 52 Chronic Lymphocytic Leukemia 52 Cimzia ® certolizumab pegol 52 molecularly targeted therapy 52 Ceflatonin R 52 Abacavir 52 NCT# ClinicalTrials.gov 52 oral taxane 52 MYOBLOC 52 elotuzumab 52 topical NSAIDs 52 CareManager 52 Follicular Lymphoma 52 colorectal liver metastases 52 Spartan RX CYP#C# 52 Dacogen injection 52 Predictive Toxicology 52 SABCS 52 bexarotene 52 interferon beta 1b 52 Myelodysplastic Syndrome MDS 52 Xarelto rivaroxaban 52 pancreatic adenocarcinoma 52 NCCN Guidelines ™ 52 Multidetector CT 52 AVADO 52 entecavir 52 Radiosurgery 52 ReValving 52 GCP compliant 52 Sanofi Aventis Taxotere 52 ILLUMINATE 52 Ablatherm 52 PharmaPros 52 BEXXAR Therapeutic Regimen 52 InForm 52 Randomised Study 52 MediServe 52 nonrandomized 52 InterStim Therapy 52 Patient Charting 52 ARIXTRA R 52 Hormone Refractory Prostate Cancer 52 pain palliation 52 TMS Therapy 52 dose escalation phase 52 APTIVUS r 52 lumiracoxib 52 Icatibant 52 MabThera rituximab 52 evaluating REVLIMID 52 occipital nerve stimulation 52 Dendreon Provenge 52 oral anticoagulants 52 Dr. Kandzari 52 aripiprazole Abilify 52 etrials EDC 52 enzastaurin 52 Aquamid 52 statin Crestor 52 Tocomin 52 Vantia Therapeutics 52 CytoCore Solutions 52 abiraterone 52 tasocitinib 52 ProSanos 52 Cotara 52 APPRAISE 52 debulking surgery 52 Egrifta 52 desvenlafaxine 52 Glivec imatinib 52 differentiated thyroid 52 pharmacoeconomic 52 IVR IWR 52 Brentuximab Vedotin SGN 52 diarrhea predominant irritable 52 Reynolds Risk Score 52 octreotide LAR 52 prospectively randomized 52 PGx 52 Chemoradiation 52 immunochemical fecal occult 52 RENAL 52 stereotactic radiation 52 radiolabeled TM# 52 Endeca Latitude 52 secretin 52 Oblicore Guarantee TM 52 intranasal corticosteroids 52 Anticancer Drug 52 adecatumumab 52 GnRH agonists 52 TRITON TIMI 52 Aggrastat ® tirofiban hydrochloride 52 mRCC 52 TRANSCEND 52 COPAXONE R 52 PharmaReady 52 Revlimid lenalidomide 52 kinase profiling 52 SCHEMA 52 peptide conjugated 52 FOLFOX4 52 talabostat 52 Oncotype DX ® 52 Phase Ib clinical 52 adjuvant radiation 52 LLLT 51 Sorafenib HCC Assessment 51 atacicept 51 recurrent metastatic 51 Clinical Therapeutics 51 ACTEMRA TM 51 Trophos 51 hematopoietic cancers 51 Clinical Trial Investigating REOLYSIN 51 PERSEUS 51 radiation therapy SBRT 51 LeadDiscovery 51 Biologics Compendium 51 dose atorvastatin 51 ziconotide 51 telemedical 51 complete cytogenetic response 51 MERLIN TIMI 51 lintuzumab 51 DRX# ™ 51 retinal specialists 51 Electroencephalography 51 Benign Prostatic Hyperplasia BPH 51 pioglitazone HCl 51 INTERPHONE study 51 ASA# 51 MALDI MS 51 Lubiprostone 51 interventional therapies 51 Systemic Lupus Erythematosus 51 OEM NIBP 51 Daclizumab 51 BRIM3 51 rALLy clinical trial 51 preclinical efficacy 51 GLOBOCAN 51 IASLC 51 metastatic renal cell carcinoma 51 Atacand 51 ongoing Phase IIIb 51 IQQA ® Liver 51 dextofisopam 51 ErbB2 positive 51 FFR measurements 51 Ceflatonin 51 Trident IWR 51 randomized controlled clinical 51 STICH 51 Symbicort SMART 51 Simcyp 51 SBRT 51 bone scintigraphy 51 paclitaxel Taxol R 51 adjuvant radiotherapy 51 Glioma 51 Reverset 51 TROPOS 51 Tarceva erlotinib 51 TargetScan 51 iPrEx 51 Oasmia 51 FDG PET 51 resected pancreatic cancer 51 clinical pharmacology studies 51 EORTC 51 AQUA ® 51 Electrophysiologists 51 unresectable tumors 51 LV dysfunction 51 observational cohort study 51 metastatic hormone refractory 51 axitinib 51 Acute MI 51 eribulin 51 Phase III psoriasis 51 Toctino ® 51 Artelon ® 51 Pharmacokinetic 51 BrainGate TM 51 Kaplan Meier analysis 51 Resolute DES 51 MedPredict 51 HCV Protease Inhibitor 51 locoregional recurrence 51 quinolone 51 Pixuvri 51 Jevtana 51 FOLPI 51 FXIII 51 Telatinib 51 GORE TAG Device 51 NCCTG 51 Parenteral Nutrition 51 Provantis ™ 51 ZOMIG Nasal Spray 51 Exco InTouch 51 UTOPY SpeechMiner 51 Lipid lowering 51 superficial bladder cancer 51 mg administered orally 51 Zebinix 51 DCVax ® Brain 51 vascular disrupting agent 51 microdosing 51 ticagrelor Brilinta 51 Torisel 51 aclidinium bromide 51 ASCO abstract 51 carotid endarterectomy CEA 51 Ixabepilone 51 estramustine 51 Chronic HCV 51 levosimendan 51 Cholesterol Levels SPARCL 51 peginterferon 51 dual endothelin receptor antagonist 51 Maple Leaf HIFU 51 DEFER 51 BR.# 51 TORISEL TM 51 Ziprasidone 51 lipid lowering drugs 51 ALPHADAS 51 Silodosin 51 certolizumab 51 Intervention Effectiveness CATIE 51 dacarbazine chemotherapy 51 Ellex 2RT 51 zalutumumab 51 targeting CD# 51 Endeavor Drug Eluting 51 intravenous bisphosphonates 51 CLARITY study 51 tarenflurbil 51 OpenClinica Enterprise 51 antiangiogenic agents 51 finasteride Proscar 51 Inhaled insulin 51 Pressure BioSciences 51 Medidur ™ FA 51 Phase Ib study 51 fallopian tube carcinoma 51 TORS 51 Gynecologic Oncology Group 51 Modrenal